Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states

Mira L. Katz; Paul L. Reiter; Brenda C. Kluhsman; Stephenie Kennedy; Sharon Dwyer; Nancy Schoenberg; Andy Johnson; Gretchen Ely; Karen A. Roberto; Eugene J. Lengerich; Pamela Brown; Electra D. Paskett; Mark Dignan

doi:10.1016/j.vaccine.2009.03.042

Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states

Mira L. Katz, Paul L. Reiter, Brenda C. Kluhsman, Stephenie Kennedy, Sharon Dwyer, Nancy Schoenberg, Andy Johnson, Gretchen Ely, Karen A. Roberto, Eugene J. Lengerich, Pamela Brown, Electra D. Paskett, Mark Dignan

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Telephone interviews of health department personnel in six states and review of an immunization database from one state were conducted to assess human papillomavirus (HPV) vaccine availability, recommendations, cost, policies, and educational materials in health departments in seven Appalachian states. Most (99.1%) health departments (n = 234) reported receiving patient requests for the HPV vaccine, and only two (1%) health departments reported that they did not provide the vaccine for patients. HPV vaccine supply was reported to not meet the demand in 10.5% (24/228) of health departments due to high costs. Level (state, region, county) at which policy about the HPV vaccine was determined, vaccine recommendations, costs, and available educational materials varied among states. This study documented variation in vaccine availability, recommendations, cost, policies, and educational materials in Appalachian health departments that could significantly affect vaccine distribution. Findings highlight the need for more comprehensive and consistent policies that maximize accessibility of the HPV vaccine to women, especially those in underserved areas.

Original language	English
Pages (from-to)	3195-3200
Number of pages	6
Journal	Vaccine
Volume	27
Issue number	24
DOIs	https://doi.org/10.1016/j.vaccine.2009.03.042
State	Published - May 21 2009

Bibliographical note

Funding Information:
This study was supported by National Cancer Institute Grants #CA113932 (Appalachia Community Cancer Network), CA107079 (MLK), and the Behavioral Measurement Shared Resource at The Ohio State University Comprehensive Cancer Center, P30 CA016058.

Keywords

Appalachian region
HPV vaccines
Health care disparities
Health policy

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2009.03.042

Cite this

Katz, M. L., Reiter, P. L., Kluhsman, B. C., Kennedy, S., Dwyer, S., Schoenberg, N., Johnson, A., Ely, G., Roberto, K. A., Lengerich, E. J., Brown, P., Paskett, E. D., & Dignan, M. (2009). Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine, 27(24), 3195-3200. https://doi.org/10.1016/j.vaccine.2009.03.042

@article{f41da245fe6a49c5881e092b1dc67939,

title = "Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states",

abstract = "Telephone interviews of health department personnel in six states and review of an immunization database from one state were conducted to assess human papillomavirus (HPV) vaccine availability, recommendations, cost, policies, and educational materials in health departments in seven Appalachian states. Most (99.1%) health departments (n = 234) reported receiving patient requests for the HPV vaccine, and only two (1%) health departments reported that they did not provide the vaccine for patients. HPV vaccine supply was reported to not meet the demand in 10.5% (24/228) of health departments due to high costs. Level (state, region, county) at which policy about the HPV vaccine was determined, vaccine recommendations, costs, and available educational materials varied among states. This study documented variation in vaccine availability, recommendations, cost, policies, and educational materials in Appalachian health departments that could significantly affect vaccine distribution. Findings highlight the need for more comprehensive and consistent policies that maximize accessibility of the HPV vaccine to women, especially those in underserved areas.",

keywords = "Appalachian region, HPV vaccines, Health care disparities, Health policy",

author = "Katz, {Mira L.} and Reiter, {Paul L.} and Kluhsman, {Brenda C.} and Stephenie Kennedy and Sharon Dwyer and Nancy Schoenberg and Andy Johnson and Gretchen Ely and Roberto, {Karen A.} and Lengerich, {Eugene J.} and Pamela Brown and Paskett, {Electra D.} and Mark Dignan",

note = "Funding Information: This study was supported by National Cancer Institute Grants #CA113932 (Appalachia Community Cancer Network), CA107079 (MLK), and the Behavioral Measurement Shared Resource at The Ohio State University Comprehensive Cancer Center, P30 CA016058. ",

year = "2009",

month = may,

day = "21",

doi = "10.1016/j.vaccine.2009.03.042",

language = "English",

volume = "27",

pages = "3195--3200",

number = "24",

}

Katz, ML, Reiter, PL, Kluhsman, BC, Kennedy, S, Dwyer, S, Schoenberg, N, Johnson, A, Ely, G, Roberto, KA, Lengerich, EJ, Brown, P, Paskett, ED & Dignan, M 2009, 'Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states', Vaccine, vol. 27, no. 24, pp. 3195-3200. https://doi.org/10.1016/j.vaccine.2009.03.042

TY - JOUR

T1 - Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states

AU - Katz, Mira L.

AU - Reiter, Paul L.

AU - Kluhsman, Brenda C.

AU - Kennedy, Stephenie

AU - Dwyer, Sharon

AU - Schoenberg, Nancy

AU - Johnson, Andy

AU - Ely, Gretchen

AU - Roberto, Karen A.

AU - Lengerich, Eugene J.

AU - Brown, Pamela

AU - Paskett, Electra D.

AU - Dignan, Mark

N1 - Funding Information: This study was supported by National Cancer Institute Grants #CA113932 (Appalachia Community Cancer Network), CA107079 (MLK), and the Behavioral Measurement Shared Resource at The Ohio State University Comprehensive Cancer Center, P30 CA016058.

PY - 2009/5/21

Y1 - 2009/5/21

N2 - Telephone interviews of health department personnel in six states and review of an immunization database from one state were conducted to assess human papillomavirus (HPV) vaccine availability, recommendations, cost, policies, and educational materials in health departments in seven Appalachian states. Most (99.1%) health departments (n = 234) reported receiving patient requests for the HPV vaccine, and only two (1%) health departments reported that they did not provide the vaccine for patients. HPV vaccine supply was reported to not meet the demand in 10.5% (24/228) of health departments due to high costs. Level (state, region, county) at which policy about the HPV vaccine was determined, vaccine recommendations, costs, and available educational materials varied among states. This study documented variation in vaccine availability, recommendations, cost, policies, and educational materials in Appalachian health departments that could significantly affect vaccine distribution. Findings highlight the need for more comprehensive and consistent policies that maximize accessibility of the HPV vaccine to women, especially those in underserved areas.

AB - Telephone interviews of health department personnel in six states and review of an immunization database from one state were conducted to assess human papillomavirus (HPV) vaccine availability, recommendations, cost, policies, and educational materials in health departments in seven Appalachian states. Most (99.1%) health departments (n = 234) reported receiving patient requests for the HPV vaccine, and only two (1%) health departments reported that they did not provide the vaccine for patients. HPV vaccine supply was reported to not meet the demand in 10.5% (24/228) of health departments due to high costs. Level (state, region, county) at which policy about the HPV vaccine was determined, vaccine recommendations, costs, and available educational materials varied among states. This study documented variation in vaccine availability, recommendations, cost, policies, and educational materials in Appalachian health departments that could significantly affect vaccine distribution. Findings highlight the need for more comprehensive and consistent policies that maximize accessibility of the HPV vaccine to women, especially those in underserved areas.

KW - Appalachian region

KW - HPV vaccines

KW - Health care disparities

KW - Health policy

UR - http://www.scopus.com/inward/record.url?scp=67349253056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349253056&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.03.042

DO - 10.1016/j.vaccine.2009.03.042

M3 - Article

C2 - 19446191

AN - SCOPUS:67349253056

SN - 0264-410X

VL - 27

SP - 3195

EP - 3200

JO - Vaccine

JF - Vaccine

IS - 24

ER -

Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this